Evidence map›Paper›PMID 35467835›Full record

ArticleAnalytical chemistry2022

Enhanced Detection of Viral RNA Species Using FokI-Assisted Digestion of DNA Duplexes and DNA/RNA Hybrids.

Juan R Tejedor, Gabriel Martín, Annalisa Roberti, Cristina Mangas, Pablo Santamarina-Ojeda, Raúl Fernández Pérez, Virginia López, Rocío González Urdinguio, Juan J Alba-Linares, Alfonso Peñarroya and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Juan R TejedorNanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego 33940, Spain.ORCID 0000-0002-4061-9698
Gabriel MartínCentral University Hospital of Asturias (HUCA), Oviedo 33011, Spain.
Annalisa RobertiNanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego 33940, Spain.
Cristina MangasFoundation for Biomedical Research and Innovation in Asturias (FINBA), Oviedo 33011, Spain.
Pablo Santamarina-OjedaFoundation for Biomedical Research and Innovation in Asturias (FINBA), Oviedo 33011, Spain.
Raúl Fernández PérezNanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego 33940, Spain.
Virginia LópezFoundation for Biomedical Research and Innovation in Asturias (FINBA), Oviedo 33011, Spain.
Rocío González UrdinguioFoundation for Biomedical Research and Innovation in Asturias (FINBA), Oviedo 33011, Spain.
Juan J Alba-LinaresNanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego 33940, Spain.
Alfonso PeñarroyaNanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego 33940, Spain.
Marta E Álvarez-ArgüellesCentral University Hospital of Asturias (HUCA), Oviedo 33011, Spain.
José A BogaCentral University Hospital of Asturias (HUCA), Oviedo 33011, Spain.
Agustín Fernández FernándezNanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego 33940, Spain.
Susana Rojo-AlbaCentral University Hospital of Asturias (HUCA), Oviedo 33011, Spain.
Mario Fernández FragaNanomaterials and Nanotechnology Research Center (CINN-CSIC), El Entrego 33940, Spain.ORCID 0000-0001-8450-2603
Universidad de Oviedo · ESHospital Universitario Central de Asturias · ESNanomaterials and Nanotechnology Research Center · ESCentre for Biomedical Network Research on Rare Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accurate detection of nucleic acids from certain biological pathogens is critical for the diagnosis of human diseases. However, amplified detection of RNA molecules from a complex sample by direct detection of RNA/DNA hybrids remains a challenge. Here, we show that type IIS endonuclease FokI is able to digest DNA duplexes and DNA/RNA hybrids when assisted by a dumbbell-like fluorescent sensing oligonucleotide. As proof of concept, we designed a battery of sensing oligonucleotides against specific regions of the SARS-CoV-2 genome and interrogated the role of FokI relaxation as a potential nicking enzyme for fluorescence signal amplification. FokI-assisted digestion of SARS-CoV-2 probes increases the detection signal of ssDNA and RNA molecules and decreases the limit of detection more than 3.5-fold as compared to conventional molecular beacon approaches. This cleavage reaction is highly specific to its target molecules, and no detection of other highly related B-coronaviruses was observed in the presence of complex RNA mixtures. In addition, the FokI-assisted reaction has a high multiplexing potential, as the combined detection of different viral RNAs, including different SARS-CoV-2 variants, was achieved in the presence of multiple combinations of fluorophores and sensing oligonucleotides. When combined with isothermal rolling circle amplification technologies, FokI-assisted digestion reduced the detection time of SARS-CoV-2 in COVID-19-positive human samples with adequate sensitivity and specificity compared to conventional reverse transcription polymerase chain reaction approaches, highlighting the potential of FokI-assisted signal amplification as a valuable sensing mechanism for the detection of human pathogens.

Indexed as

COVID-19SARS-CoV-2DigestionDNAHumansNucleic Acid Amplification TechniquesOligonucleotidesRNA, ViralSensitivity and SpecificityDNAOligonucleotidesRNA, Viral

Identifiers

PMID35467835
PMCPMC9063116
OpenAlexW4224597197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.